According to the American Academy of Dermatology (AAD), there will be approximately one million new cases of skin cancer diagnosed in the United States in 2008. The AAD says that about one in every five Americans will develop skin cancer some time during his/her lifetime. The most common types of skin cancer are basal cell and squamous cell carcinomas. Fortunately, they are easy to treat if detected early.

This post is an original post by ScienceDaily: Skin Care News

Posted: June 30th, 2008 under skin health.
Comments: none

According to the American Academy of Dermatology (AAD), there will be approximately one million new cases of skin cancer diagnosed in the United States in 2008. The AAD says that about one in every five Americans will develop skin cancer some time during his/her lifetime. The most common types of skin cancer are basal cell and squamous cell carcinomas. Fortunately, they are easy to treat if detected early.

This post is an original post by ScienceDaily: Skin Care News

Posted: June 30th, 2008 under skin health.
Comments: none

Pain Therapeutics, Inc. recently announced the successful completion of its first clinical study utilizing a novel melanoma treatment, which the company licensed from Albert Einstein College of Medicine of Yeshiva University. The treatment consisted of dosing patients with a monoclonal antibody labeled with a radioisotope. A research team at Einstein, led by Arturo Casadevall, M.D., Ph.D., professor and chairman of microbiology & immunology, and Ekaterina Dadachova, Ph.D.

This post is an original post by ScienceDaily: Skin Care News

Posted: June 27th, 2008 under skin health.
Comments: none

HUMIRA (adalimumab) has today been recommended by the National Institute for Health and Clinical Excellence (NICE) as a treatment option for adults with severe chronic plaque psoriasis.1 Adalimumab is the only fully human anti-TNF (tumour necrosis factor) monoclonal antibody licensed for the treatment of plaque psoriasis in the UK.

This post is an original post by ScienceDaily: Skin Care News

Posted: June 26th, 2008 under skin health.
Comments: none

HUMIRA (adalimumab) has today been recommended by the National Institute for Health and Clinical Excellence (NICE) as a treatment option for adults with severe chronic plaque psoriasis.1 Adalimumab is the only fully human anti-TNF (tumour necrosis factor) monoclonal antibody licensed for the treatment of plaque psoriasis in the UK.

This post is an original post by ScienceDaily: Skin Care News

Posted: June 26th, 2008 under skin health.
Comments: none

For many of us the summer is a time to think about taking a break, enjoying long hot days in the sun, sitting on a beach or swimming in the sea. But for people living with a skin disease called psoriasis the summer is often viewed with dread. Psoriasis is a skin condition which affects 2% of the population and takes the form of scaly, silver scales on the skin which when removed show very red sore angry skin.

This post is an original post by ScienceDaily: Skin Care News

Posted: June 26th, 2008 under skin health.
Comments: none

The National Institute for Health and Clinical Excellence (NICE) has published guidance on the use of adalimumab for the treatment of psoriasis in adults.

This post is an original post by ScienceDaily: Skin Care News

Posted: June 26th, 2008 under skin health.
Comments: none

With warmer weather, extended daylight hours, and a host of outdoor activities to enjoy everyday, the summer season beckons all comers to take advantage of more time under the sun. With the official start of summer having launched, experts at Northwestern Memorial Hospital warn against overexposure to the sun, which can lead to heat-related illness.

This post is an original post by ScienceDaily: Skin Care News

Posted: June 25th, 2008 under skin health.
Comments: none

Unexplained skin irritations, itchy rashes it happens to millions of Americans and many say they have no idea what causes the breakouts. According to experts jewelry allergies are not only extremely common, but very simple to prevent.”We see it quite frequently,” says Lisa Garner, M.D., dermatologist on the medical staff at Baylor Medical Center at Garland. “Some patients come in and actually realize what’s going on and others do not have any idea what’s causing their rash.

This post is an original post by ScienceDaily: Skin Care News

Posted: June 24th, 2008 under skin health.
Comments: none

A child’s risk of developing eczema in the first year can be increasedby a combination of a specific genetic mutation in the proteinfilaggrin (FLG) and exposure to a cat, according to a study released onJune 23, 2008 in the open access journal PLoS Medicine.Eczema is a skin disease characterized by inflammation of the outerlayers of the skin, and symptoms include dry, red, and itchypatches on the skin.

This post is an original post by ScienceDaily: Skin Care News

Posted: June 24th, 2008 under skin health.
Comments: none